In contrast, MM has more diverse mutation patterns, with less than 20% of BRAFV600E mutations (16), followed by the majority of mutations that are scattered and difficult to target, including NRAS, NF1, KIT, SF3B1, and SPRED1 (21). This evidence concerns the gene NRAS and Miyoshi myopathy.